Skip to content

Evaluation of Two Daily Disposable Contact Lenses for Wearers With Astigmatism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01207466
Enrollment
95
Registered
2010-09-23
Start date
2010-09-30
Completion date
2010-10-31
Last updated
2012-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia

Brief summary

The purpose of this trial is to compare the performance of two contact lenses for contact lens wearers with astigmatism.

Interventions

DEVICENelfilcon A investigational contact lens

Investigational, soft contact lens for astigmatism worn on a daily disposable basis.

DEVICENelfilcon A commercial contact lens

Commercially marketed, soft contact lens for astigmatism worn on a daily disposable basis.

Sponsors

CIBA VISION
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Currently wearing soft contact lenses with astigmatism correction * Other protocol inclusion criteria may apply

Exclusion criteria

* Eye injury or surgery within twelve weeks prior to enrollment * Currently enrolled in an ophthalmic clinical trial * Strabismus * Any use of medications for which contact lens wear could be contraindicated as determined by the investigator * Other protocol

Design outcomes

Primary

MeasureTime frameDescription
Quality of Vision (Crisp and Clear)1 week of wearQuality of vision (crisp and clear), as interpreted and reported by the participant by eye on a questionnaire as a single, retrospective evaluation of one week's wear time. Quality of vision was assessed on a 10-point scale, with 1 being poor and 10 being excellent.

Participant flow

Pre-assignment details

This reporting group includes all enrolled and dispensed participants. One participant was enrolled but not dispensed due to unacceptable fit. This participant is included in the Actual Enrollment calculation, but not Participant Flow or Baseline Characteristics calculations.

Participants by arm

ArmCount
Overall
This reporting group includes all enrolled and dispensed subjects.
94
Total94

Baseline characteristics

CharacteristicOverall
Age Continuous35.8 years
STANDARD_DEVIATION 12.2
Sex: Female, Male
Female
56 Participants
Sex: Female, Male
Male
38 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 950 / 93
serious
Total, serious adverse events
0 / 950 / 93

Outcome results

Primary

Quality of Vision (Crisp and Clear)

Quality of vision (crisp and clear), as interpreted and reported by the participant by eye on a questionnaire as a single, retrospective evaluation of one week's wear time. Quality of vision was assessed on a 10-point scale, with 1 being poor and 10 being excellent.

Time frame: 1 week of wear

Population: Analysis conducted per protocol, with exclusions due to reasons such as: major protocol deviations as determined by masked review; discontinuations; and/or missing responses.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon A InvestigationalQuality of Vision (Crisp and Clear)8.8 units on a scaleStandard Deviation 1.3
Nelfilcon A CommercialQuality of Vision (Crisp and Clear)8.6 units on a scaleStandard Deviation 1.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026